The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
Open accessAbstract
OBJECTIVE: To determine the short-term and long-term risks of tuberculosis (TB) associated with CD4 cell recovery during antiretroviral therapy (ART). DESIGN: Observational community-based ART cohort in South Africa. METHODS: TB incidence was determined among patients (n = 1480) receiving ART for up to 4.5 years in a South African community-based service. Updated CD4 cell counts were measured 4-monthly. Person-time accrued within a range of CD4 cell count strata (CD4 cell strata) was calculated and used to derive CD4 cell-stratified TB rates. Factors associated with incident TB were identified using Poisson regression models. RESULTS: Two hundred and three cases of TB were diagnosed during 2785 person-years of observation (overall incidence, 7.3 cases/100 person-years). During person-time accrued within CD4 cell strata 0-100, 101-200, 201-300, 301-400, 401-500 and more than 500 cells/microl unadjusted TB incidence rates were 16.8, 9.3, 5.5, 4.6, 4.2 and 1.5 cases/100 person-years, respectively (P < 0.001). During early ART (first 4 months), adjusted TB rates among those with CD4 cell counts 0-200 cells/microl were 1.7-fold higher than during long-term ART (P = 0.026). Updated CD4 cell counts were the only patient characteristic independently associated with long-term TB risk. CONCLUSION: Updated CD4 cell counts were the dominant predictor of TB risk during ART in this low-resource setting. Among those with baseline CD4 cell counts less than 200 cells/microl, the excess adjusted risk of TB during early ART was consistent with 'unmasking' of disease missed at baseline screening. TB incidence rates at CD4 cell counts of 200-500 cells/microl remained high and adjunctive interventions are required. TB prevention would be improved by ART policies that minimized the time patients spend with CD4 cell counts below a threshold of 500 cells/microl.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745
Self-citationEarly mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
Self-citationBadri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 556
Self-citationLawn, S. D., Bekker, L.-G., & Miller, R. F. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70140-7 · Cited by 545
Self-citationLedergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., et al. (1999) · JAMA · doi:10.1001/jama.282.23.2220 · Cited by 481
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2006) · AIDS · doi:10.1097/01.aids.0000238406.93249.cd · Cited by 363
Self-citationLawn, S. D., Myer, L., Orrell, C., Bekker, L.-G., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194802.89540.e1 · Cited by 359
Self-citationLawn, S. D., Badri, M., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194808.20035.c1 · Cited by 352
Self-citationImmunological recovery and antiretroviral therapy in HIV-1 infection
Battegay, M., Nüesch, R., Hirschel, B., & Kaufmann, G. R. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70463-7 · Cited by 255
Wood, R., Middelkoop, K., Myer, L., Grant, A. D., Whitelaw, A., Lawn, S. D., Kaplan, G., Huebner, R., McIntyre, J., & Bekker, L.-G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200606-759oc · Cited by 239
Self-citationAntiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS
Williams, B. G., & Dye, C. (2003) · Science · doi:10.1126/science.1086845 · Cited by 235
Lawn, S. D., Bekker, L.-G., Middelkoop, K., Myer, L., & Wood, R. (2006) · Clinical Infectious Diseases · doi:10.1086/501018 · Cited by 233
Self-citationLawn, S. D., Myer, L., Harling, G., Orrell, C., Bekker, L.-G., & Wood, R. (2006) · Clinical Infectious Diseases · doi:10.1086/507095 · Cited by 226
Self-citationMoore, D., Liechty, C., Ekwaru, P., Were, W., Mwima, G., Solberg, P., Rutherford, G., & Mermin, J. (2007) · AIDS · doi:10.1097/qad.0b013e328013f632 · Cited by 217
Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral Therapy
Lawn, S. D., Wilkinson, R. J., Lipman, M. C. I., & Wood, R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1311pp · Cited by 202
Self-citationLawn, S. D., Edwards, D. J., Kranzer, K., Vogt, M., Bekker, L.-G., & Wood, R. (2009) · AIDS · doi:10.1097/qad.0b013e32832e05c8 · Cited by 191
Self-citationMtei, L., Matee, M., Herfort, O., Bakari, M., Horsburgh, C. R., Waddell, R., Cole, B. F., Vuola, J. M., Tvaroha, S., Kreiswirth, B., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429825 · Cited by 189
Santoro-Lopes, G., Felix de Pinho, A. M., Harrison, L. H., & Schechter, M. (2002) · Clinical Infectious Diseases · doi:10.1086/338641 · Cited by 167
Lawn, S. D., Bekker, L.-G., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000176211.08581.5a · Cited by 165
Self-citationGirardi, E., Antonucci, G., Vanacore, P., Libanore, M., Errante, I., Matteelli, A., & Ippolito, G. (2000) · AIDS · doi:10.1097/00002030-200009080-00015 · Cited by 164
Bekker, L., Myer, L., Orrell, C., Lawn, S. D., & Wood, R. (2006) · PubMed · doi:10.7196/samj.1072 · Cited by 158
Self-citationConservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited
Orrell, C., Harling, G., Lawn, S. D., Kaplan, R., McNally, M., Bekker, L., & Wood, R. (2007) · Antiviral Therapy · doi:10.1177/135965350701200106 · Cited by 142
Self-citationHIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Jones, J. L., Hanson, D. L., Ms, D., et al. (2000) · PubMed · Cited by 136
Corbett, E. L., Bandason, T., Cheung, Y. B., Munyati, S. S., Godfrey‐Faussett, P., Hayes, R., Churchyard, G., Butterworth, A. E., & Mason, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0040022 · Cited by 135
Lawn, S. D., Myer, L., Bekker, L., & Wood, R. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-59 · Cited by 134
Self-citationChanging mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa
Lawn, S. D., Little, F., Bekker, L., Kaplan, R., Campbel, E., Orrell, C., & Wood, R. (2009) · AIDS · doi:10.1097/qad.0b013e328321823f · Cited by 134
Self-citationBonnet, M., Pinoges, L., Varaine, F., Oberhauser, B., O'Brien, D. P., Kebede, Y. Y., Hewison, C., Zachariah, R., & Ferradini, L. (2006) · AIDS · doi:10.1097/01.aids.0000232235.26630.ee · Cited by 92
Breen, R. A. M., Smith, C. J., Cropley, I. M., Johnson, M. A., & Lipman, M. C. I. (2005) · AIDS · doi:10.1097/01.aids.0000176221.33237.67 · Cited by 89
Tuberculosis Preventive Therapy in the Era of HIV Infection: Overview and Research Priorities
Churchyard, G., Scano, F., Grant, A. D., & Chaisson, R. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/518662 · Cited by 83
Day, J., Charalambous, S., Fielding, K., Hayes, R., Churchyard, G., & Grant, A. D. (2006) · PubMed · Cited by 79
Lawn, S. D., Wainwright, H., & Orrell, C. (2008) · AIDS · doi:10.1097/qad.0b013e32831d2a98 · Cited by 71
Self-citationLawn, S. D., Edwards, D., & Wood, R. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.387 · Cited by 8
Self-citation
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,242
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
Self-citationHIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Understanding Latent Tuberculosis: A Moving Target
Lin, P. L., & Flynn, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903856 · Cited by 488
Metadata
- Authors
- Lawn, S. D., Myer, L., Edwards, D., Bekker, L.-G., & Wood, R.
- Venue
- AIDS
- Published
- 2009-08-24
- Volume
- 23
- Issue
- 13
- Pages
- 1717-1725
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2091328187
- Cited by
- 338
- References
- 35
- FWCI
- 23.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.